Smoking after coronary artery bypass: High three-year mortality

Thoracic and Cardiovascular Surgeon

Volumn 57, Issue 3, 2009, Pages 135-140

  Lindsay, G M ^b   Tolmie, E P ^b   Martin, W M ^c   Hutton, I M ^a   Belcher, P R ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

^c GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Artery; Cardiovascular surgery; Coronary bypass surgery; Heart disease; Ischaemia; Smoking

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITRATE; POTASSIUM CHANNEL BLOCKING AGENT; THALLIUM; WARFARIN;

ADULT; ALCOHOL CONSUMPTION; ANGINA PECTORIS; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DYSPNEA; FEMALE; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBESITY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; STRESS; WAIST CIRCUMFERENCE; AGED; BLOOD; BLOOD PRESSURE; DRINKING BEHAVIOR; FOLLOW UP; HEART STROKE VOLUME; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; SMOKING; STATISTICAL MODEL; TIME; TREATMENT OUTCOME;

AGED; ALCOHOL DRINKING; ANGINA PECTORIS; BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DIABETES COMPLICATIONS; DYSPNEA; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; OBESITY; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SMOKING; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; WAIST CIRCUMFERENCE;

EID: 67449096144     PISSN: 01716425     EISSN: 14391902     Source Type: Journal    
DOI: 10.1055/s-2008-1039271     Document Type: Article

References (28)

1. National Institute of Health Consensus. Development conference statement: coronary artery bypass surgery; scientific and clinical aspects. N Engl J Med 1981;304:680-684
2. Alderman EL, Corley SD, Fisher LD et al. Five year angiographic followup of factors associated with progression of coronary artery disease in the Coronary Artery Surgery Study (CASS). CASS participating investigators and staff. J Am Coll Cardiol 1993;22:1141-1154
3. Lindsay GM, Smith LN, Hanlon P, Wheatley DJ. The influence of general health status and social support on symptomatic outcome following coronary artery bypass grafting. Heart 2001;85:80-86
4. Belcher PR, Gaw A, Cooper M, Brown M, Wheatley DJ, Lindsay GM. Are we negating the benefits of coronary artery bypass grafting? J Human Hypertens 2002;16:691-697
5. Lindsay GM, Hanlon WP, Smith LN, Belcher PR. Experience of cardiac rehabilitation after coronary artery surgery: effects on health and risk factors. Int J Cardiol 2002;87:67-73
6. Tolmie EP, Lindsay GM, Belcher PR. Coronary artery bypass graft operation: patients' experience of health and well-being over time. Eur J Cardiovasc Nursing 2006;5:228-236
7. Scott J, Huskisson EC. Graphic representation of pain. Pain 1976;2:175-184
8. Martin W, Tweddle AC, McGhie AI, Hutton I. Gated thallium scintigraphy in patients with coronary artery disease: an improved planar imaging technique. Clin Phys Physiol Meas 1987;8:343-354
9. Simons LA, Simons J, Parfitt A. Coronary risk factors 6-12 months after coronary artery bypass grafting. Comparison of surveys in 1986, 1990 and 1994. Med J Aust 1994;161:536-537
10. Herlitz J, Haglid M, Albertsson P et al. Short-and long-term prognosis after coronary artery bypass grafting in relation to smoking habits. Cardiology 1997;88:492-497
11. McLeod AL, Brooks L, Taylor V, Currie PF, Dewhurst NG. Secondary prevention for coronary artery disease. QJM 2004;97:127-131
12. van Domburg RT, Meeter K, van Berkel DF, Veldkamp RF, van Herwerden LA, Bogers AJ. Smoking cessation reduces mortality after coronary artery bypass surgery: a 20-year follow-up study. J Am Coll Cardiol 2000;36:878-883
13. Hilleman DE, Mohiuddin SM, Packard KA. Comparison of conservative and aggressive smoking cessation treatment strategies following coronary artery bypass graft surgery. Chest 2004;125:435-438
14. Ilia R, Carmel S, Carlos C, Gueron M. Relation between shortness of breath, left ventricular end diastolic pressure and severity of coronary artery disease. Int J Cardiol 1995;52:153-155
15. Baskett RJ, Buth KJ, Collicott C, Ross DB, Hirsch GM. Preoperative cardiovascular risk factor control in elective coronary artery bypass graft patients: a failure of present management. Can J Cardiol 2002;18:397-402
16. Herlitz J. Secondary prevention after coronary artery bypass grafting - what do we know? Scand Cardiovasc J 2004;38:69-74
17. Sever P, Beevers G, Bulpitt C et al. Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society. Br Med J 1993;306:983-987
18. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, Horan MJ, Labarthe D. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995;25:305-313
19. Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyorala K. Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Atherosclerosis 1998;140:199-270
20. Lean ME, Han TS, Seidell JC. Impairment of health and quality of life in people with large waist circumference. Lancet 1998;351:853-856
21. Emberson JR, Whincup PH, Lawlor DA, Montaner D, Ebrahim S. Coronary heart disease prevention in clinical practice: are patients with diabetes special? Evidence from two studies of older men and women. Heart 2005;91:451-455
22. EUROASPIRE I and II Group; European Action on Secondary Prevention by Intervention to Reduce Events. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events. Lancet 2001;357:995-1001
23. Brady AJ, Oliver MA, Pittard JB. Secondary prevention in 24431 patients with coronary heart disease: survey in primary care. Br Med J 2001;322:1463
24. Bradshaw PJ, Jamrozik K, Gilfillan I, Thompson PL. Preventing recurrent events long term after coronary artery bypass graft: suboptimal use of medications in a population study. Am Heart J 2004;147:1047-1053
25. Singer DE, Albers GW, Dalen JE, Go AS, Halperin JL, Manning WJ. Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(Suppl. 3):429S-456S
26. Cox J, Naylor CD. The Canadian Cardiovascular Society grading scale for angina pectoris: is it time for refinements? Ann Intern Med 1992;117:677-683
27. Asakuma S, Fujiwara M, Ohyanagi M, Iwasaki T. A simple reliable method of assessing exercise capacity in patients with chronic heart failure. Med Sci Sports Exerc 1999;31:52-56
28. Lindsay GM, Tolmie EM, Brodie E, Niven CA, Belcher PR. Accuracy of patient recall of symptoms post-CABG. J Clin Nursing (in press)